SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Lyka Labs Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
500259 INE933A01014 30.0720157 LYKALABS 0 408.33 0 0 10
Quarters :
ParticularsDec 2023(Rs.Cr)Sep 2023(Rs.Cr)Jun 2023(Rs.Cr)
Gross Sales31.4226.7621.24
Other Operating Income0.000.000.00
Other Income 0.520.300.43
Total Income31.9427.0621.67
Total Expenditure 25.5622.8718.68
PBIDT6.384.192.99
Interest 1.261.171.33
PBDT5.123.021.65
Depreciation2.723.463.34
Tax0.910.100.24
Fringe Benefit Tax0.000.000.00
Deferred Tax0.13-0.25-0.20
Reported Profit After Tax1.36-0.29-1.72
Extra-ordinary Items 0.00-0.030.00
Adjusted Profit After Extra-ordinary item1.36-0.26-1.72
    
EPS (Unit Curr.)0.40-0.10-0.54
EPS (Adj) (Unit Curr.)0.40-0.10-0.54
Calculated EPS (Unit Curr.)0.41-0.09-0.52
Calculated EPS (Adj) (Unit Curr.)0.41-0.09-0.52
Calculated EPS (Ann.) (Unit Curr.)1.65-0.35-2.08
Calculated EPS (Adj) (Ann.) (Unit Curr.)1.65-0.35-2.08
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity33.0933.0933.09
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)20.3115.6614.08
PBDTM(%)16.3011.297.77
PATM(%)4.33-1.08-8.10